Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Ann Med. 2024 Dec;56(1):2357230. doi: 10.1080/07853890.2024.2357230. Epub 2024 May 30.
Understanding changes in vaccine hesitancy, overall and by sociodemographic characteristics, may highlight sub-populations for whom more intensive efforts are needed to increase vaccine uptake and confidence.
We analyzed data using the CDC's Research and Development Survey (RANDS), a nationally representative survey of U.S. adults ≥18 years, collected from 17 May 2021-30 June 2021 ( = 5,458) and 3 November 2022-12 December 2022 ( = 6,821). We assessed changes in vaccine hesitancy, changes in vaccine attitudes and attitudes, and factors associated with hesitancy toward both vaccines in general and COVID-19 vaccines among a nationally representative sample of U.S. adults.
Although COVID-19 vaccination (≥1 dose) increased from 67.2% (2021) to 74.7% (2022), COVID-19 vaccine hesitancy increased from 40.7% to 44.6% during the same period. During the same period, hesitancy toward both COVID-19 vaccines and vaccines in general increased among those who were aged ≥65 years and who were non-Hispanic White. However, COVID-19 vaccine hesitancy decreased among non-Hispanic Black adults. Current or former smokers were more hesitant toward vaccines in general (aPR = 1.13, 95%CI: 1.03-1.24) and toward COVID-19 vaccines (aPR = 1.08, 95%CI: 1.01-1.16) compared to never smokers. Among adults who did not receive any COVID-19 vaccines, COVID-19 vaccine hesitancy increased from 86.6% in 2021 to 92.4% in 2022. Furthermore, belief in the overall social benefit of the COVID-19 vaccine decreased from 47.5% to 25.1%.
This study highlights concerning trends in vaccine hesitancy and uptake of the COVID-19 and other recommended vaccines. We found that some high-risk groups (e.g. smokers) and population subgroups have become more vaccine hesitant, suggesting the need for improved and intensified strategies to increase vaccine confidence and uptake. Future research may focus on qualitative inquiry to understand specific concerns and determinants contributing to increased hesitancy among these groups to help inform interventions and communication campaigns to support vaccination.
了解疫苗犹豫情绪的变化,包括整体变化和按社会人口特征的变化,可能会突出需要更加强化努力来提高疫苗接种率和信心的亚人群。
我们使用疾病预防控制中心的研究与发展调查(RANDS)的数据进行分析,这是一项对美国≥18 岁成年人的全国代表性调查,于 2021 年 5 月 17 日至 6 月 30 日( = 5458)和 2022 年 11 月 3 日至 12 月 12 日( = 6821)期间收集。我们评估了一般疫苗和 COVID-19 疫苗的犹豫情绪、疫苗态度和态度的变化,以及一般疫苗和 COVID-19 疫苗的犹豫情绪与某些因素之间的关系,在一个具有全国代表性的美国成年人样本中。
尽管 COVID-19 疫苗(≥1 剂)的接种率从 2021 年的 67.2%上升到 2022 年的 74.7%,但同期 COVID-19 疫苗犹豫情绪从 40.7%上升到 44.6%。同期,≥65 岁和非西班牙裔白人的 COVID-19 疫苗和一般疫苗的犹豫情绪都有所增加。然而,非西班牙裔黑人成年人的 COVID-19 疫苗犹豫情绪有所下降。目前或以前的吸烟者对一般疫苗(aPR = 1.13,95%CI:1.03-1.24)和 COVID-19 疫苗(aPR = 1.08,95%CI:1.01-1.16)的犹豫情绪高于从不吸烟者。在未接种任何 COVID-19 疫苗的成年人中,COVID-19 疫苗犹豫情绪从 2021 年的 86.6%上升到 2022 年的 92.4%。此外,对 COVID-19 疫苗的总体社会效益的信念从 47.5%下降到 25.1%。
本研究强调了疫苗犹豫和 COVID-19 及其他推荐疫苗接种率令人担忧的趋势。我们发现,一些高风险群体(如吸烟者)和人群亚组变得更加犹豫不决,这表明需要改进和加强策略,以提高疫苗信心和接种率。未来的研究可能集中在定性研究上,以了解导致这些群体犹豫不决的具体问题和决定因素,以帮助为干预措施和传播运动提供信息,以支持疫苗接种。